Please use this identifier to cite or link to this item:
Title: Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
Austin Authors: Klein, Oliver ;Kee, Damien ;Nagrial, Adnan;Markman, Ben;Underhill, Craig;Michael, Michael;Behren, Andreas;Palmer, Jodie ;Tebbutt, Niall C ;Carlino, Matteo S;Cebon, Jonathan S 
Affiliation: Medical Oncology
Blacktown Hospital, Blacktown, New South Wales, Australia.
Department of Medical Oncology, Alfred Health, Prahran, Victoria, Australia.
Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, New South Wales, Australia.
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Olivia Newton-John Cancer Research Institute
Blacktown Hospital, Blacktown, New South Wales, Australia.
Issue Date: 1-Apr-2023
Date: 2023
Publication information: Cancer 2023-04-01; 129(7)
DOI: 10.1002/cncr.34660
ORCID: 0000-0003-0022-9553
Journal: Cancer
Start page: 1129
End page: 1130
PubMed URL: 36692958
ISSN: 1097-0142
Type: Journal Article
Subjects: Antibodies, Monoclonal/therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jun 16, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.